Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.33%Shareholder Yield
VS
Market
Sector
Industry
History
$ 14.31Close
$ 8.21 - $ 14.6 52-Week Range
Ticker Information
Ticker
TBPHCompany Name
THERAVANCE BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTHERAVANCE BIOPHARMA INC - Shareholder Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TBPH - Shareholder Yield Historical data
| Date | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
|---|---|---|---|---|---|
| 6/30/2025 | $ 625.49M | $ -2.09M | $ 0 | $ 0 | 0.33% |
| 3/31/2025 | $ 440.01M | $ -1.64M | $ 0 | $ 0 | 0.37% |
| 12/31/2024 | $ 471.46M | $ -2.5M | $ 0 | $ 0 | 0.53% |
| 9/30/2024 | $ 470.6M | $ -32.74M | $ 0 | $ 0 | 6.96% |
| 6/30/2024 | $ 375.72M | $ -63.77M | $ 0 | $ 0 | 16.97% |
| 3/31/2024 | $ 479.04M | $ -144.41M | $ 0 | $ 0 | 30.15% |
| 12/31/2023 | $ 454.67M | $ -198.93M | $ 0 | $ 0 | 43.75% |
| 9/30/2023 | $ 501.46M | $ -203.8M | $ 0 | $ 0 | 40.64% |
| 6/30/2023 | $ 538.69M | $ -267.09M | $ -631.6M | $ 0 | 166.83% |
| 3/31/2023 | $ 662.94M | $ -186.27M | $ -631.6M | $ 0 | 123.37% |
Key Performance Insights, Last 5 Years
- THERAVANCE BIOPHARMA INC's latest trailing twelve months (TTM) Shareholder Yield stands at -23.28%.
- Over the past 5 years, THERAVANCE BIOPHARMA INC's average Shareholder Yield has been 27.63%.
- The median Shareholder Yield for THERAVANCE BIOPHARMA INC during this period was 0.64%
- THERAVANCE BIOPHARMA INC reached its highest Shareholder Yield over the past 5 years at 166.83%.
- The lowest Shareholder Yield recorded by THERAVANCE BIOPHARMA INC in the same timeframe -25.18%
THERAVANCE BIOPHARMA INC's Shareholder Yield vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Shareholder Yield Benchmarks
Similar metrics to Shareholder Yield:
- Payout Yield - [Calculation] The Payout Yield describes the percentage a business is returning to its shareholders in the form of share buybacks and dividends.
- Buyback Yield - [Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
Definition of Shareholder Yield
[Calculation] The Shareholder Yield is a ratio that indicates how much money the business is giving back to shareholders. A business can return to shareholders through dividends [DivYield], share repurchases [BuybackYield], and debt reduction [DebtPaydownYield].(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield Shareholder Yield for THERAVANCE BIOPHARMA INC is calculated as follows: (-1 * CF - Equity [ $ 135.09M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 131.03M ]) / Market Cap [ $ 1.14B ]
(=) Shareholder Yield [ -23.28% ] TBPH - Shareholder Yield, Last 5 years
-25.18%
Minimum
Dec 31, 2020
166.83%
Maximum
Jun 30, 2023
27.63%
Average
0.64%
Median
Shareholder Yield Benchmark AnalysisMarket
The chart above depicts the distribution of Shareholder Yield for companies in the Total Stock Market. The average Shareholder Yield of the companies is 0.57% with a standard deviation of 11.13%.
The following table provides additional summary stats:
Shareholder Yield in the Market:
| filtered constituents | 3.48K |
|---|---|
| min | -33.43% |
| max | 34.45% |
| average | 0.57% |
| median | 1.07% |
| std | 11.13% |